These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32213769)

  • 1. The Multicomponent, Multitarget Therapy SUC in Cats with Chronic Kidney Disease: A Multicenter, Prospective, Observational, Nonrandomized Cohort Study.
    Brandenburg U; Braun G; Klein P; Reinhart E
    Complement Med Res; 2020; 27(3):163-173. PubMed ID: 32213769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Efficacy of Long-term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease.
    Sent U; Gössl R; Elliott J; Syme HM; Zimmering T
    J Vet Intern Med; 2015; 29(6):1479-87. PubMed ID: 26474314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Chinese rhubarb, Rheum officinale, with and without benazepril on the progression of naturally occurring chronic kidney disease in cats.
    Hanzlicek AS; Roof CJ; Sanderson MW; Grauer GF
    J Vet Intern Med; 2014; 28(4):1221-8. PubMed ID: 24773179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability and efficacy of benazepril in cats with chronic kidney disease.
    King JN; Gunn-Moore DA; Tasker S; Gleadhill A; Strehlau G;
    J Vet Intern Med; 2006; 20(5):1054-64. PubMed ID: 17063696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the clinical efficacy of benazepril in the treatment of chronic renal insufficiency in cats.
    Mizutani H; Koyama H; Watanabe T; Kitagawa H; Nakano M; Kajiwara K; King JN
    J Vet Intern Med; 2006; 20(5):1074-9. PubMed ID: 17063698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Benazepril on Survival of Dogs with Chronic Kidney Disease: A Multicenter, Randomized, Blinded, Placebo-Controlled Clinical Trial.
    King JN; Font A; Rousselot JF; Ash RA; Bonfanti U; Brovida C; Crowe ID; Lanore D; Pechereau D; Seewald W; Strehlau G
    J Vet Intern Med; 2017 Jul; 31(4):1113-1122. PubMed ID: 28669137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective case-control study of the effects of long-term dosing with meloxicam on renal function in aged cats with degenerative joint disease.
    Gowan RA; Lingard AE; Johnston L; Stansen W; Brown SA; Malik R
    J Feline Med Surg; 2011 Oct; 13(10):752-61. PubMed ID: 21906984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of benazepril hydrochloride in cats with experimentally induced or spontaneously occurring chronic renal failure.
    Watanabe T; Mishina M
    J Vet Med Sci; 2007 Oct; 69(10):1015-23. PubMed ID: 17984588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency.
    Brown SA; Brown CA; Jacobs G; Stiles J; Hendi RS; Wilson S
    Am J Vet Res; 2001 Mar; 62(3):375-83. PubMed ID: 11277203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Double-blind, Placebo-controlled, Multicenter, Prospective, Randomized Study of Beraprost Sodium Treatment for Cats with Chronic Kidney Disease.
    Takenaka M; Iio A; Sato R; Sakamoto T; Kurumatani H;
    J Vet Intern Med; 2018 Jan; 32(1):236-248. PubMed ID: 29131397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of benazepril in cats with heart disease in a prospective, randomized, blinded, placebo-controlled clinical trial.
    King JN; Martin M; Chetboul V; Ferasin L; French AT; Strehlau G; Seewald W; Smith SGW; Swift ST; Roberts SL; Harvey AM; Little CJL; Caney SMA; Simpson KE; Sparkes AH; Mardell EJ; Bomassi E; Muller C; Sauvage JP; Diquélou A; Schneider MA; Brown LJ; Clarke DD; Rousselot JF
    J Vet Intern Med; 2019 Nov; 33(6):2559-2571. PubMed ID: 31560137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic use of maropitant for the management of vomiting and inappetence in cats with chronic kidney disease: a blinded, placebo-controlled clinical trial.
    Quimby JM; Brock WT; Moses K; Bolotin D; Patricelli K
    J Feline Med Surg; 2015 Aug; 17(8):692-7. PubMed ID: 25336450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of hallmarks of carbonyl stress and formation of end products in feline chronic kidney disease as markers of uraemic toxins.
    Valle E; Prola L; Vergnano D; Borghi R; Monacelli F; Traverso N; Bruni N; Bovero A; Schiavone A; Nery J; Bergero D; Odetti P
    J Feline Med Surg; 2019 Jun; 21(6):465-474. PubMed ID: 30015556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of benazepril for advanced chronic renal insufficiency.
    Hou FF; Zhang X; Zhang GH; Xie D; Chen PY; Zhang WR; Jiang JP; Liang M; Wang GB; Liu ZR; Geng RW
    N Engl J Med; 2006 Jan; 354(2):131-40. PubMed ID: 16407508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in cats with chronic kidney disease.
    King JN; Tasker S; Gunn-Moore DA; Strehlau G;
    J Vet Intern Med; 2007; 21(5):906-16. PubMed ID: 17939542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Can angiotensin-converting enzyme inhibitor be used in chronic kidney disease patients with serum creatinine level greater than 266 micromol/L?].
    Zhang GH; Hou FF; Zhang X; Liu QF
    Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):592-6. PubMed ID: 16194413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary F
    Whitehouse W; Quimby J; Wan S; Monaghan K; Robbins R; Trepanier LA
    J Vet Intern Med; 2017 Mar; 31(2):449-456. PubMed ID: 28160524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
    Maschio G; Alberti D; Janin G; Locatelli F; Mann JF; Motolese M; Ponticelli C; Ritz E; Zucchelli P
    N Engl J Med; 1996 Apr; 334(15):939-45. PubMed ID: 8596594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease.
    Quimby JM; Benson KK; Summers SC; Saffire A; Herndon AK; Bai S; Gustafson DL
    J Feline Med Surg; 2020 Apr; 22(4):376-383. PubMed ID: 31161850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-arterial renal infusion of autologous mesenchymal stem cells for treatment of chronic kidney disease in cats: Phase I clinical trial.
    Thomson AL; Berent AC; Weisse C; Langston CE
    J Vet Intern Med; 2019 May; 33(3):1353-1361. PubMed ID: 30924554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.